BBB Therapeutics

About BBB Therapeutics

BBB Therapeutics is a clinical stage biotechnology company developing novel treatments for devastating brain disorders, such as brain cancer and neuroinflammatory diseases. The Company combines existing drugs with BBB Therapeutics'​ proprietary G-TechnologyĂ‚Ĺ˝ for enhanced drug delivery across the blood-brain barrier. BBB Therapeutics currently has two products in clinical trials: its lead product 2B3-101 is in a Phase IIa trial in Europe and the US for the treatment of primary brain tumors as well as brain metastases; the second product 2B3-201 for MS relapses and other neuroinflammatory diseases is completing a Phase I clinical study.

Keywords

• Blood-Brain Barrier
• Brain Cancer
• Drug Delivery
• Neuroinflammation

Address

• Headquarters

  J.H. Oortweg 192333CH LeidenZuid-Holland, Netherlands